- Home
- AWH vs PMCB Comparison
AWH vs PMCB Comparison
Compare AWH & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWH
- PMCB
- Stock Information
- Founded
- AWH 1993
- PMCB 1996
- Country
- AWH United States
- PMCB United States
- Employees
- AWH N/A
- PMCB N/A
- Industry
- AWH Medical/Dental Instruments
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AWH Health Care
- PMCB Health Care
- Exchange
- AWH Nasdaq
- PMCB Nasdaq
- Market Cap
- AWH 11.7M
- PMCB 13.9M
- IPO Year
- AWH N/A
- PMCB N/A
- Fundamental
- Price
- AWH $0.81
- PMCB $1.65
- Analyst Decision
- AWH Buy
- PMCB
- Analyst Count
- AWH 2
- PMCB 0
- Target Price
- AWH $4.40
- PMCB N/A
- AVG Volume (30 Days)
- AWH 76.2K
- PMCB 15.6K
- Earning Date
- AWH 11-14-2024
- PMCB 12-24-2024
- Dividend Yield
- AWH N/A
- PMCB N/A
- EPS Growth
- AWH N/A
- PMCB N/A
- EPS
- AWH N/A
- PMCB 0.74
- Revenue
- AWH $8,963,000.00
- PMCB N/A
- Revenue This Year
- AWH $11.87
- PMCB N/A
- Revenue Next Year
- AWH $79.10
- PMCB N/A
- P/E Ratio
- AWH N/A
- PMCB $2.27
- Revenue Growth
- AWH N/A
- PMCB N/A
- 52 Week Low
- AWH $0.67
- PMCB $1.39
- 52 Week High
- AWH $5.65
- PMCB $2.58
- Technical
- Relative Strength Index (RSI)
- AWH 50.69
- PMCB 45.07
- Support Level
- AWH $0.68
- PMCB $1.61
- Resistance Level
- AWH $0.90
- PMCB $1.81
- Average True Range (ATR)
- AWH 0.07
- PMCB 0.11
- MACD
- AWH 0.00
- PMCB 0.00
- Stochastic Oscillator
- AWH 49.09
- PMCB 43.64
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.